Literature DB >> 9400462

Adjuvant radiation therapy does not cause urinary incontinence after radical prostatectomy: results of a prospective randomized study.

P J Van Cangh1, F Richard, F Lorge, Y Castille, A Moxhon, R Opsomer, L De Visscher, F X Wese, P Scaillet.   

Abstract

PURPOSE: We analyzed the potential influence of adjuvant radiotherapy on urinary continence after radical prostatectomy.
MATERIALS AND METHODS: A total of 100 patients with N0M0 prostate cancer randomized in a prospective study on postoperative radiotherapy for locally advanced disease (positive surgical margin, capsular perforation and/or seminal vesicle infiltration) were studied. Objective pad weighing tests corroborated by direct personal interviews were used to evaluate urinary continence at regular postoperative intervals.
RESULTS: Of the patients 48 received 60 Gy. external radiotherapy with 18 MV photon beams between 12 and 16 weeks postoperatively, and 52 were followed expectantly. Risk factors were similar in both groups. With a mean followup of 24 months, no difference in complete urinary continence was observed. Of the irradiated group 77% and of the surveillance group 83% were totally dry. The fate of the bladder neck had no significant influence on final continence status, although there was a trend for faster recovery when the bladder neck was preserved.
CONCLUSIONS: In this prospective randomized study 60 Gy. external radiation therapy administered between 3 and 4 months after radical prostatectomy for pathologically locally advanced prostate cancer had no significant influence on urinary continence.

Entities:  

Mesh:

Year:  1998        PMID: 9400462     DOI: 10.1016/s0022-5347(01)64044-8

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  18 in total

1.  Shared responsibility for treatment-related morbidity for prostate cancer.

Authors:  Joseph L Chin; Glenn Bauman
Journal:  Can Urol Assoc J       Date:  2010-04       Impact factor: 1.862

2.  Meta-analysis of the effect of postoperative radiotherapy on prognosis of prostatic cancer following radical prostatectomy.

Authors:  Fan He; Zhenqiang Fang; Chongxing Shen; Longkun Li
Journal:  Int J Clin Exp Med       Date:  2015-11-15

Review 3.  [Recurrence of prostate cancer--value of salvage radiotherapy].

Authors:  C Belka; U Ganswindt
Journal:  Urologe A       Date:  2006-10       Impact factor: 0.639

4. 

Authors:  Joseph L Chin
Journal:  Can Urol Assoc J       Date:  2009-06       Impact factor: 1.862

5.  pT3N0M0 prostate cancer: a plea for adjuvant radiation.

Authors:  Michel Bolla; Laurence Collette
Journal:  Nat Rev Urol       Date:  2009-08       Impact factor: 14.432

6.  [No negative effect of percutaneous radiotherapy on continence after radical prostatectomy--the results of a prospective randomized study].

Authors:  T Wiegel
Journal:  Strahlenther Onkol       Date:  1998-10       Impact factor: 3.621

Review 7.  Radiation therapy for prostate cancer after prostatectomy: adjuvant or salvage?

Authors:  Amit R Patel; Andrew J Stephenson
Journal:  Nat Rev Urol       Date:  2011-06-14       Impact factor: 14.432

8.  Physician beliefs and practices for adjuvant and salvage radiation therapy after prostatectomy.

Authors:  Timothy N Showalter; Nitin Ohri; Kristopher G Teti; Kathleen A Foley; Scott W Keith; Edouard J Trabulsi; Costas D Lallas; Adam P Dicker; Jean Hoffman-Censits; Laura T Pizzi; Leonard G Gomella
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-05-24       Impact factor: 7.038

Review 9.  Adjuvant radiation therapy after radical prostatectomy: when is it indicated?

Authors:  Stephen M Graham; Jeffrey M Holzbeierlein
Journal:  Curr Urol Rep       Date:  2009-05       Impact factor: 3.092

10.  Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy.

Authors:  Andrew J Stephenson; Peter T Scardino; Michael W Kattan; Thomas M Pisansky; Kevin M Slawin; Eric A Klein; Mitchell S Anscher; Jeff M Michalski; Howard M Sandler; Daniel W Lin; Jeffrey D Forman; Michael J Zelefsky; Larry L Kestin; Claus G Roehrborn; Charles N Catton; Theodore L DeWeese; Stanley L Liauw; Richard K Valicenti; Deborah A Kuban; Alan Pollack
Journal:  J Clin Oncol       Date:  2007-05-20       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.